Sowell Financial Services’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-93
Closed -$638K 545
2021
Q2
$638K Hold
93
0.04% 384
2021
Q1
$568K Buy
93
+5
+6% +$41.9K 0.02% 601
2020
Q4
$708K Buy
88
+4
+5% +$36K 0.03% 421
2020
Q3
$855K Sell
84
-1
-1% -$8.2K 0.04% 337
2020
Q2
$568K Sell
85
-3
-3% -$20.7K 0.03% 419
2020
Q1
$400K Buy
88
+53
+151% +$265K 0.03% 457
2019
Q4
$211K Buy
35
+8
+30% +$51.1K 0.02% 695
2019
Q3
$192K Buy
+27
New +$197K 0.02% 658

Other funds holding RDHL

Sowell Financial Services's RDHL Position: Q3 2021 in Review

Sowell Financial Services sold out of Redhill Biopharma (RDHL) in Q3 2021, closing a stake of 93 shares — an estimated $638K sold.

Sowell Financial Services first reported a position in RDHL in Q3 2019 and held it in 8 quarters. The position peaked at $855K in Q3 2020. 53 funds tracked by Wall St. Rank hold RDHL as of Q3 2021.

  • Sowell Financial Services reported no remaining Redhill Biopharma position as of Q3 2021 after selling out during the quarter.
  • Sowell Financial Services sold 93 Redhill Biopharma shares in Q3 2021, an estimated $638K.
  • Sowell Financial Services first reported a position in Redhill Biopharma in Q3 2019 and held it in 8 quarters.
  • Sowell Financial Services's Redhill Biopharma position peaked at $855K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2021.

Based on Sowell Financial Services's 13F filing for Q3 2021, filed 4 Nov 2021.